Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus midazolam for prevention of preprocedural agitation in children undergoing bone marrow procedures
IRCT20191104045328N9Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in agitation comparing Dexmedetomidine group with Midazolam group (2 arms). Primary endpoints: 4-point sedation scale at 30 minutes, Respiratory rate at 30 minutes and 3 more. Started Apr 2022; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
agitation
Beyond the preview
Go deeper on IRCT20191104045328N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N9.